Unknown

Dataset Information

0

Translational research in brain metastasis is identifying molecular pathways that may lead to the development of new therapeutic strategies.


ABSTRACT: Central nervous system (CNS) or brain metastasis is an emerging area of interest in organ-specific metastasis research. Lung and breast cancers are the most common types of primary tumors to develop brain metastases. This disease complication contributes significantly to the morbidity and mortality of both of these common cancers; as such, brain metastasis is designated an unmet medical need by the US Food and Drug Administration (FDA). Recently, an increase in incidence of CNS disease has been noted in the literature for breast cancer, while it has been an ongoing major complication from lung cancer. Progress in treating brain metastases has been hampered by a lack of model systems, a lack of human tissue samples, and the exclusion of brain metastatic patients from many clinical trials. While each of those is significant, the major impediment to effectively treating brain metastatic disease is the blood-brain barrier (BBB). This barrier excludes most chemotherapeutics from the brain and creates a sanctuary site for metastatic tumors. Recent findings on the biology of this disease and translational leads identified by molecular studies are discussed in this article.

SUBMITTER: Gril B 

PROVIDER: S-EPMC2858326 | biostudies-literature | 2010 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Translational research in brain metastasis is identifying molecular pathways that may lead to the development of new therapeutic strategies.

Gril Brunilde B   Evans Lynda L   Palmieri Diane D   Steeg Patricia S PS  

European journal of cancer (Oxford, England : 1990) 20100319 7


Central nervous system (CNS) or brain metastasis is an emerging area of interest in organ-specific metastasis research. Lung and breast cancers are the most common types of primary tumors to develop brain metastases. This disease complication contributes significantly to the morbidity and mortality of both of these common cancers; as such, brain metastasis is designated an unmet medical need by the US Food and Drug Administration (FDA). Recently, an increase in incidence of CNS disease has been  ...[more]

Similar Datasets

| S-EPMC5528619 | biostudies-literature
| S-EPMC8505648 | biostudies-literature
| S-EPMC4792555 | biostudies-literature
| S-EPMC7328353 | biostudies-literature
| S-EPMC6885158 | biostudies-literature
| S-EPMC5985267 | biostudies-literature
| S-EPMC3188867 | biostudies-literature
| S-EPMC10526208 | biostudies-literature
| S-EPMC3419626 | biostudies-literature
| S-EPMC11116067 | biostudies-literature